Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Will Arrowhead Pharmaceuticals Be a Biotech Winner?
11:02am, Tuesday, 19'th May 2020
A leading company in the field of gene silencing is on track to develop several breakthrough therapies.
RBC Capital Initiates Coverage On Arrowhead Pharmaceuticals with Outperform Rating, Announces Price Target of $62
08:59am, Wednesday, 13'th May 2020Hallador Energy Co (HNRG) CEO Brent Bilsland on Q1 2020 Results - Earnings Call Transcript
10:29pm, Tuesday, 12'th May 2020
Hallador Energy Co (NASDAQ:HNRG) Q1 2020 Earnings Conference Call May 12, 2020, 14:00 ET Company Participants Rebecca Palumbo - Director, IR Lawrence Martin - E
Investors in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) had a good week, as its shares rose 4.9% to close at...
Edited Transcript of ARWR earnings conference call or presentation 7-May-20 8:30pm GMT
02:38am, Saturday, 09'th May 2020
Q2 2020 Arrowhead Pharmaceuticals Inc Earnings Call
Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2020 Earnings Call Transcript
01:30am, Saturday, 09'th May 2020
Thank you for joining us today to discuss Arrowhead's results for its fiscal second quarter ended March 31, 2020. With us today from management are President and CEO, Dr. Christopher Anzalone, who wi
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q2 2020 Results - Earnings Call Transcript
03:39pm, Friday, 08'th May 2020
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2020 Earnings Conference Call May 07, 2020 04:30 PM ET Company Participants Vincent Anzalone - Vice President o
Xconomy: Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More
02:33pm, Friday, 08'th May 2020
Alexion Pharmaceuticals CEO Ludwig Hantson has made no secret that he wants to diversify his company’s drug portfolio and he has shown willingness to open
17 Healthcare Stocks Moving In Friday's Pre-Market Session
11:50am, Friday, 08'th May 2020Arrowhead Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 sales results.
11:18am, Friday, 08'th May 2020Cantor Fitzgerald Reiterates Overweight on Arrowhead Pharmaceuticals, Lowers Price Target to $58
11:02am, Friday, 08'th May 2020Wallabies star Poidevin's evidence lacking credibility, tribunal finds
07:04am, Friday, 08'th May 2020
The Administrative Appeals Tribunal has delivered a stinging final blow to former Bell Potter managing director Simon Poidevin, saying he gave evidence that was unreliable.
Arrowhead Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 sales results.
09:02pm, Thursday, 07'th May 2020Arrowhead Pharmaceuticals Q2 EPS $(0.200) Misses $(0.110) Estimate, Sales $23.528M Beat $21.740M Estimate
08:01pm, Thursday, 07'th May 2020Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results
08:00pm, Thursday, 07'th May 2020
Arrowhead Pharmaceuticals reports fiscal Q2 2020 earnings
